Company intelligence / Profile preview

DexCare

Seattle, Washington, United Statesdexcare.com ↗

Ownership: Private
Employees: ~183
Development stage: Commercial

Overview

DexCare provides a commercialized digital care orchestration platform used by major U.S. health systems to optimize patient access, manage capacity, and improve operational efficiency. The company reports significant impact on new patient acquisition and system throughput but does not conduct clinical trials as it does not develop drugs or devices.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy (software platform; not a drug or biologic company)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Providence HealthKaiser PermanenteMass General BrighamCommunity Health NetworkTexas Health Resources

Beyond the preview

Go deeper on DexCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DexCare.

Explore the full profile